Researchers from Advance Health Solutions, Naval Medical Center San Diego, Naval Hospital Okinawa, Washington, DC's Department of Behavioral Health and The University of Texas MD Anderson Cancer Center disseminate the following PRESS RELEASE to highlight results form their collaborative research study featured in the Journal of Anesthesia and Clinical Research.
Reports of Patients Successfully Treated by Army, Navy and Civilian Doctors Give Hope that a Biologic Approach to Managing PTSD Is On the Horizon
WASHINGTON, DC, June 9, 2014 – A study showing that the use of local anesthetics can help rapidly improve persistent symptoms of post-traumatic stress disorder (PTSD) has been published in the current issue of the Journal of Anesthesia and Clinical Research. The study, which was led by researchers from Advance Health Solutions and experts in military psychiatry and anesthesiology, is a consolidation of all published case reports and case series on the use of a neck injection procedure known as stellate ganglion block (SGB) to treat patients who have tried and otherwise failed conventional PTSD therapies.
The study was led by epidemiologist Dr. Maryam Navaie who says the key message from the research is compelling and especially meaningful in its June publication release given this month has been designated by Congress to include PTSD Awareness Day (S. Res. 455). Said Navaie: “Our article shows that SGB rapidly reduces chronic PTSD symptoms in patients treated across the country by Army, Navy, and civilian doctors alike. The growing evidence-base from multiple credible institutions caring for active duty service members, veterans and civilians who suffer from PTSD is consistent and impressive when examined in its totality”. US Navy Captain and Head of Pain Management in the Department of Anesthesiology at Naval Hospital Okinawa, Dr. Anita H. Hickey, a co-author of the study, agrees. Said Hickey: “The large scale of human suffering and financial costs associated with persistent PTSD requires that we continue to search for additional treatment options. SGB offers a promising, novel and safe approach for the treatment of PTSD without the risks and side effects associated with medications. Being a common pain management procedure, SGB is in a position to be studied widely and more rigorously to discern which patients might best benefit from this treatment".
Retired Army psychiatrist and renowned military PTSD expert, Colonel Elspeth Cameron Ritchie, M.D., M.P.H., who also authored the study says that SGB offers new hope for many patients who either resist or have had little success with traditional treatments. Said Ritchie: “While some treatments for PTSD do exist, many sufferers refuse to go, either because they worry about re-exposing themselves to trauma or about medication side-effects. One of the exciting aspects of this stellate ganglion procedure is that, for some, it leads to a dramatic reduction in symptoms in a very short period of time with minimal or no side effects. We do not yet know enough about which patient populations it will benefit though. More research into this promising modality is clearly needed, but this review is a great springboard to get there”. Dr. Ritchie is currently the Chief Medical Officer at the Department of Behavioral Health in Washington, DC. Fellow psychiatrist Robert N. McLay, M.D., Ph.D. who oversees research studies specific to various treatments for PTSD in the Department of Mental Health at Naval Medical Center San Diego concurs with Dr. Ritchie: "If this works, SGB is just about the ideal treatment for PTSD. We found that all the case reports about the procedure were positive. That’s encouraging. But the plural of ‘anecdote’ is not ‘science.’ We also found that there were no formal studies testing SGB for PTSD. Clearly, those will be needed in the future.”
SGB expert and another study co-author, Salahadin Abdi, M.D., Ph.D., Professor and Chairman in Department of Pain Medicine, Division of Anesthesiology and Critical Care at The University of Texas MD Anderson Cancer Center said that bringing anesthesiologists and psychiatrists under one roof to advance treatment options for PTSD was a particularly rewarding experience because it pushes research into previously uncharted territory. Said Abdi: "This is a small step forward towards understanding and the acceptance of a commonly performed interventional pain procedure, SGB, for the treatment of PTSD given the fact that current options are inadequate. Thinking outside the box!"
Contact: Dr. Maryam Navaie at (202) 507-5635 or via email at mnavaie@advancehealthsolutions.com. To download the published research article, click this link.